Sort
64,565 grants matching “drug discovery”
Discovery of Bifunctional NOP/Opioid Receptor Ligands for Drug Abuse Therapy
$646,183Nurulain T Zaveri · Astraea Therapeutics, Llc · R01 · FY2011 · DA
Research and Development of Effective Therapies for Patients with Rare Tumors
$646,140Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
Selective disruption of histone deacetylase complexes using protein interaction modulators
$646,119Marc Vidal · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Immobilized Proteins In Drug Discovery
$646,076Josephine Earley · National Institute On Aging · ZIA · FY2017 · AG
Behavior-based discovery of small-molecule modulators of neurochemical signaling pathways that underlie addiction
$646,068Niels Ringstad · New York University School Of Medicine · R01 · FY2022 · DA
Innate Immune Control of TB and HIV
$646,050Anne Goldfeld · Boston Children'S Hospital · R56 · FY2021 · AI
Prevention of neonatal opioid withdrawal syndrome
$646,029Gary A Peltz · Stanford University · R01 · FY2018 · HD
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling
$646,003Thomas E Ferrin · University Of California, San Francisco · R01 · FY2020 · GM
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling
$646,003Thomas E Ferrin · University Of California, San Francisco · R01 · FY2021 · GM
In Silico Screening of Medications for Slowing Alzheimer's Disease Progression.
$645,978Richard E Kennedy · University Of Alabama At Birmingham · R01 · FY2021 · AG
In Silico Screening of Medications for Slowing Alzheimer's Disease Progression.
$645,978Richard E Kennedy · University Of Alabama At Birmingham · R01 · FY2018 · AG
In Silico Screening of Medications for Slowing Alzheimer's Disease Progression.
$645,978Richard E Kennedy · University Of Alabama At Birmingham · R01 · FY2020 · AG
In Silico Screening of Medications for Slowing Alzheimer's Disease Progression.
$645,978Richard E Kennedy · University Of Alabama At Birmingham · R01 · FY2019 · AG
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
$645,976David Eric Gerber · Ut Southwestern Medical Center · U10 · FY2016 · CA
Repurposing novel selective drugs for treatment and decolonization of vancomycin resistant enterococci
$645,971Mohamed Seleem · Virginia Polytechnic Inst And St Univ · R01 · FY2021 · AI
Zebrafish Lipid Metabolism Assay for Drug Screening
$645,969Zygogen, Llc · R44 · FY2004 · DK
Non Alcoholic Steatohepatitis Clinical Research Network
$645,943Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2021 · DK
Microarray Chips for Rapid Detection of High Affinity Nucleic Acid Sequences.
$645,864Mark Patrick McPike · Aptamatrix, Inc. · R44 · FY2008 · GM
New Methods for Catalytic Asymmetric Synthesis of Valuable Chemicals
$645,840Larry E Overman · University Of California-Irvine · · FY2006 · MPS
Small molecule Hsp90 inhibitors in AD treatment
$645,822Gabriela Chiosis · Sloan-Kettering Inst Can Research · U01 · FY2013 · AG
Molecular mechanisms of bacterial homologs of neurotransmitter:sodium symporters
$645,811Jonathan A Javitch · Columbia University Health Sciences · R01 · FY2011 · DA
INTEGRATED PLACENTAL IMAGING: NOVEL METHODS FOR PROBING FUNCTION AND METABOLISM
$645,778Joel Richard Garbow · Washington University · R01 · FY2016 · HD
Chemical Strategies to Reveal Cellular Glycation and Ubiquitination
$645,712Rebecca Scheck · Tufts University Medford · R35 · FY2025 · GM
CORE II - Genetics & Informatics Using Statistics CORE (GENIUS)
$645,662Nancy J. Cox · University Of Chicago · U01 · FY2011 · GM
Towards Therapeutics for Neurodegenerative Diseases
$645,645Stanley B Prusiner · University Of California, San Francisco · R37 · FY2017 · AG